Atlas Trials

t(9;22)

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch t(9;22)

RecordFirmDate
Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia (NCT03576547)M.D. Anderson Cancer Center2018-06-26
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia (NCT03263572)M.D. Anderson Cancer Center2017-11-29
Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia. (NCT00390793)M.D. Anderson Cancer Center2006-09-28

Track t(9;22) automatically

Every clearance here is in the API, with alerts when new ones post.